4.4 Article

Precision therapy for a medically actionable ATP1A3 variant from a genomic medicine program in an underserved population

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pediatrics

The influence of social determinants of health on the genetic diagnostic odyssey: who remains undiagnosed, why, and to what effect?

Yarden S. Fraiman et al.

Summary: Despite Mendelian genetic disorders being individually rare, they are collectively more common and contribute significantly to pediatric morbidity and mortality. Advancements in genetic testing have allowed for individualized treatment plans and could potentially improve quality of life, but ensuring equitable access remains a challenge. Further research is needed to address disparities in pediatric genetic testing and to provide precision medicine to all who can benefit.

PEDIATRIC RESEARCH (2021)

Review Clinical Neurology

ATP1A3-Related Disorders: An Ever-Expanding Clinical Spectrum

Philippe A. Salles et al.

Summary: The Na+/K+ ATPases are a critical part of cell membrane function, with the ATP1A3 gene encoding the α 3 isoform which is associated with neurological disorders. Pathogenic variants in this gene can lead to a range of symptoms, often presenting with acute onset and triggered episodes by fever or other factors.

FRONTIERS IN NEUROLOGY (2021)

Article Clinical Neurology

Alternating Hemiplegia of Childhood: Genotype-Phenotype Correlations in a Cohort of 39 Italian Patients

Ramona Cordani et al.

Summary: In a cohort of Italian children with Alternating Hemiplegia of Childhood, 92.3% were found to have mutations in the ATP1A3 gene, with the p.Glu815Lys mutation associated with more severe symptoms. Patients with the p.Glu815Lys mutation exhibited earlier onset of paralysis and tonic attacks, as well as greater intellectual disability and language impairment. Interestingly, the medication flunarizine appeared to be more effective in patients with the p.Glu815Lys mutation compared to those with the p.Asp801Asn mutation.

FRONTIERS IN NEUROLOGY (2021)

Review Genetics & Heredity

Alternating Hemiplegia of Childhood: Understanding the Genotype-Phenotype Relationship of ATP1A3 Variations

Alessandro Capuano et al.

APPLICATION OF CLINICAL GENETICS (2020)

Review Clinical Neurology

ATP1A3-related disorders: An update

Miryam Carecchio et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2018)

Article Genetics & Heredity

Clinical profile of patients with ATP1A3 mutations in Alternating Hemiplegia of Childhood-a study of 155 patients

Eleni Panagiotakaki et al.

ORPHANET JOURNAL OF RARE DISEASES (2015)

Review Clinical Neurology

Distinct neurological disorders with ATP1A3 mutations

Erin L. Heinzen et al.

LANCET NEUROLOGY (2014)

Editorial Material Pharmacology & Pharmacy

Next-generation disadvantages: identifying potential barriers to integrating genomics into underserved medical settings

Aaron J. Goldenberg et al.

PERSONALIZED MEDICINE (2013)

Article Genetics & Heredity

De novo mutations in ATP1A3 cause alternating hemiplegia of childhood

Erin L. Heinzen et al.

NATURE GENETICS (2012)

Review Clinical Neurology

The treatment and management of alternating hemiplegia of childhood

B. G. R. Neville et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2007)